Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Nat Cancer. 2020 Jul 6;1(7):672–680. doi: 10.1038/s43018-020-0088-5

Table 1 ∣.

Summary of dormancy- and reactivation-inducing Factor

Factor In vitro
data
In vivo
data
Human
data
Refs.
Dormancy inducers CXCL12 Y Y Y 65
vWF Y Y N 23
TGFβ2 Y Y N 36
BMP4, BMP7 Y Y N 43,48
Hypoxia Y Y Y 33
GAS6 Y Y N 115,116
RA Y Y N 46
LIF Y Y N 97
TSP1 Y Y N 31
WNTs Y Y N 27,117
DNA methylation repressive chromatin state Y Y Y 46,72
Wnt5a Y Y N 72
Axolotl embryo Y N N 86
miR-126 Y Y Y 104
Jagged 1 Y Y N 118
Reactivation inducers COCO Y Y Y 48
Inflammation and NETs Y Y Y 32,75,76
Stiff collagen Y Y N 79
Aging Y Y Y 78,79,119
VCAM1 Y Y N 60
Periostin Y Y N 31
TGFβ1 Y Y N 36

Known cancer cell- and microenvironment-derived regulators that promote the dormancy or reactivation of dormant cancer cells in solid and liquid cancers. The type of data available for each factor is also indicated. These findings are compiled from different cancer types and thus these signaling pathways might not all be associated with the dormancy of every type of cancer or microenvironment. Y, yes; N, no.